Market
MOA signed last year after 2023 MOU Details may change depending on negotiations

Celltrion will build a finished-product (DP) plant worth 300 billion won in Yesan County, South Chungcheong Province.
Celltrion disclosed the plan on the 25th in a filing clarifying a rumor or media report (not yet confirmed).
According to the filing, Celltrion signed a memorandum of agreement (MOA) on Feb. 27 last year with South Chungcheong Province, Yesan County and Chungnam Development Corp. to invest 300 billion won in a new finished-product plant.
Previously, on Nov. 30, 2023, Celltrion signed a memorandum of understanding (MOU) with Yesan County to invest 300 billion won in a new plant for biopharmaceuticals and related materials by December 2028.
The company said details, including the investment period and amount, may change depending on negotiations.
Celltrion plans to issue another disclosure when specific details are finalized or within six months. The scheduled date for the next disclosure is Feb. 24 next year.
The disclosure officer is Shin Min-cheol, head of the management division.

BIOBOOK TEAM
biobookmedia@biobook.co.kr
Medtronic to Acquire Contego Medical for $380 Million, Strengthening Carotid Treatment Portfolio

AstraZeneca wins Soliris antitrust lawsuit, with court finding no patent abuse

Alphabet Subsidiary Isomorphic Raises $5 Billion for AI Drug Development

Google Subsidiary Isomorphic Raises Another $5 Billion in Funding in Six Months

Lilly invests $7.9 billion in cancer-targeting technology company in fourth deal in 6 weeks

Samsung Biologics Completes 2.665 Trillion Won Rights Offering; New Shares to List Nov. 30